Another BMJ Study—This Time Actos—Shows Over 80% Cancer Risk

Chaffin Luhana LLP alerted diabetes patients of a new study in the British Medical Journal that indicates taking Actos creates a higher risk of Actos bladder cancer than previously believed. New York, NY (PRWEB) June 13, 2012 Chaffin Luhana LLP, a national plaintiffs-only law firm, alerted diabetes patients of a new study in the British Medical Journal (BMJ) that indicates taking Actos creates a higher risk of Actos bladder cancer than previously believed. Last year, the FDA warned that those taking the drug for longer than a year could have an increased risk of the disease, but the recent
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations